Background Percutaneous patent foramen ovale (PFO) closure is an established intervention for secondary prevention of ...
Background Antiretroviral therapy (ART)-treated people with HIV (PWH) have increased risk of heart failure with preserved ...
Background Up to 30% of patients undergoing transcatheter aortic valve implantation (TAVI) have presented to hospital with ...
Background and objectives The History, ECG, Age, Risk factors and Troponin (HEART) score is widely used for emergency ...
Ivermectin, on the WHO’s List of Essential Medications, has been in clinical use since 1981 as an orally and topically active agent for treating a range of parasitic infections in humans, including ...
Background The expansion of universal health coverage (UHC) in many low- and middle-income countries (LMICs) has occurred alongside a growing burden of chronic disease and multimorbidity. Heart ...
Objective This study aimed to evaluate the safety and efficacy of transapical epicardial temporary pacemaker lead implantation compared with the conventional transvenous approach in patients ...
Background Diagnosing heart failure with preserved ejection fraction (HFpEF) can be challenging because natriuretic peptide (NP) plasma levels and diastolic function parameters during rest ...
Background NT-proBNP is a key biomarker in heart failure (HF). Patients with markedly elevated levels are at high risk of adverse outcomes but experience delays in specialist care. Evidence on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results